Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea

Diabetes Care - United States
doi 10.2337/dc06-0564
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Rosiglitazone in Combination With Glimepiride Plus Metformin in Type 2 Diabetic Patients

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2002English

Effects of Exenatide Plus Rosiglitazone on -Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2010English

Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2017English

Intensive Insulin Titration With Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients in Turkey: LANTIT Study

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Patients With Type 2 Diabetes Inadequately Controlled on Premixed Insulin: Effect of Initiating Insulin Glargine Plus Oral Antidiabetic Agents on Glycaemic Control in Daily Practice*

International Journal of Clinical Practice
Medicine
2007English

Effect of Telmisartan Versus Captopril on Insulin Resistance in Hypertensive Type 2 Diabetic Patients

Mosul Journal of Nursing
2014English

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Comparison of Insulin, Sulfonylurea and Sulfonylureas-Metformin Combination on HbA1c and eGFR Level on Age-, Sex- And BMI-Matched Groups of Indonesian Type 2 DM Patients

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2018English

Efficacy and Safety of LY2963016 Insulin Glargine in Patients With Type 1 and Type 2 Diabetes Previously Treated With Insulin Glargine

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy